leadf
logo-loader
viewNaturally Splendid Enterprises Ltd.

Full interview: Naturally Splendid teams with Biologic Pharmamedical for a Phase 2 clinical study

Naturally Splendid (CVE: NSP- OTC: NSPDF) CEO Craig Goodwin and Biologic Pharmamedical CEO Franco Cavaleri joined Steve Darling from Proactive Vancouver to share details the two companies have formed a joint venture for the purpose of further developing and pursuing phase 2 clinical studies, utilizing one of Biologic's patented technologies as a candidate for a potential COVID 19 treatment.

Goodwin discusses the joint venture while Cavaleri shares the details about the study what the timing will look like.

Quick facts: Naturally Splendid Enterprises Ltd.

Price: 0.045 CAD

TSX-V:NSP
Market: TSX-V
Market Cap: $9.08 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Naturally Splendid Enterprises Ltd. named herein, including the promotion by the Company of Naturally Splendid Enterprises Ltd. in any Content...

FOR OUR FULL DISCLAIMER CLICK HERE

Naturally Splendid signs deal with another food distributer for their Natera...

Naturally Splendid (CVE: NSP- OTC: NSPDF) President and CEO Craig Goodwin joined Steve Darling from Proactive with news the company has signed another distribution deal for 3 of their Natera Plant-Based foods. Goodwin telling Proactive the new distributor will be stocking schnitzel and two...

1 day, 22 hours ago

2 min read